Last reviewed · How we verify
Beta-lactam plus levofloxacin combination therapy
Beta-lactam plus levofloxacin combination therapy is a Small molecule drug developed by Mahidol University. It is currently FDA-approved.
At a glance
| Generic name | Beta-lactam plus levofloxacin combination therapy |
|---|---|
| Sponsor | Mahidol University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP (PHASE4)
- Oral Antimicrobial Treatment vs. Outpatient Parenteral for Infective Endocarditis (PHASE4)
- Early Antibiotics After Aspiration in ICU Patients (PHASE4)
- Beta-lactam Plus Levofloxacin to Enhance Therapy in Streptococcal Septicemia (PHASE4)
- Appropriateness of Antibiotic Combination Therapy for Severe Community-acquired Pneumonia in South Korea (NA)
- Comparison of Keverprazan Hydrochloride-Amoxicillin Dual Therapy and Susceptibility-Guided Quadruple Therapy for Helicobacter Pylori Rescue Treatment (PHASE3)
- Efficacy of Oral vs IV Antibiotics in the Treatment of Orofacial Osteomyelitis (PHASE4)
- Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Beta-lactam plus levofloxacin combination therapy CI brief — competitive landscape report
- Beta-lactam plus levofloxacin combination therapy updates RSS · CI watch RSS
- Mahidol University portfolio CI
Frequently asked questions about Beta-lactam plus levofloxacin combination therapy
What is Beta-lactam plus levofloxacin combination therapy?
Beta-lactam plus levofloxacin combination therapy is a Small molecule drug developed by Mahidol University.
Who makes Beta-lactam plus levofloxacin combination therapy?
Beta-lactam plus levofloxacin combination therapy is developed and marketed by Mahidol University (see full Mahidol University pipeline at /company/mahidol-university).
What development phase is Beta-lactam plus levofloxacin combination therapy in?
Beta-lactam plus levofloxacin combination therapy is FDA-approved (marketed).